Caroline Thompson to Registries
This is a "connection" page, showing publications Caroline Thompson has written about Registries.
Connection Strength
1.717
-
Soppe SE, Peacock Hinton S, Halula JC, Lund JL, Baggett CD, Pruitt SL, Mullins MA, Dillon EC, Barclay ME, Thompson M, Pettit N, Lyratzopoulos G, Thompson CA. Registry versus claims-based index dates for studies of cancer diagnosis in administrative data. Cancer Causes Control. 2025 May; 36(5):539-550.
Score: 0.762
-
Thompson CA, Jin A, Luft HS, Lichtensztajn DY, Allen L, Liang SY, Schumacher BT, Gomez SL. Population-Based Registry Linkages to Improve Validity of Electronic Health Record-Based Cancer Research. Cancer Epidemiol Biomarkers Prev. 2020 04; 29(4):796-806.
Score: 0.543
-
Obrochta CA, Murphy JD, Tsou MH, Thompson CA. Disentangling Racial, Ethnic, and Socioeconomic Disparities in Treatment for Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2021 08; 30(8):1546-1553.
Score: 0.149
-
DeRouen MC, Thompson CA, Canchola AJ, Jin A, Nie S, Wong C, Jain J, Lichtensztajn DY, Li Y, Allen L, Patel MI, Daida YG, Luft HS, Shariff-Marco S, Reynolds P, Wakelee HA, Liang SY, Waitzfelder BE, Cheng I, Gomez SL. Integrating Electronic Health Record, Cancer Registry, and Geospatial Data to Study Lung Cancer in Asian American, Native Hawaiian, and Pacific Islander Ethnic Groups. Cancer Epidemiol Biomarkers Prev. 2021 08; 30(8):1506-1516.
Score: 0.148
-
Parada H, Agalliu I, Sotres-Alvarez D, Olshan AF, Evenson KR, Rohan TE, Kaplan RC, Thompson CA, Gallo LC, Penedo FJ, Cai J, Wassertheil-Smoller S, Thyagarajan B, Thomas SN, Garcia-Bedoya OL, Daviglus ML, Talavera GA. Cancer Incidence in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)-The Onco-SOL Ancillary Study. Cancer Epidemiol Biomarkers Prev. 2025 Apr 03; 34(4):491-499.
Score: 0.048
-
Sangaramoorthy M, Yang J, Guan A, DeRouen MC, Tana MM, Somsouk M, Thompson CA, Gibbons J, Ho C, Chu JN, Cheng I, Gomez SL, Shariff-Marco S. Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update. Cancer Epidemiol Biomarkers Prev. 2022 02; 31(2):382-392.
Score: 0.038
-
Afghahi A, Purington N, Han SS, Desai M, Pierson E, Mathur MB, Seto T, Thompson CA, Rigdon J, Telli ML, Badve SS, Curtis CN, West RB, Horst K, Gomez SL, Ford JM, Sledge GW, Kurian AW. Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer. Clin Cancer Res. 2018 06 15; 24(12):2851-2858.
Score: 0.030